Health
Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes – News-Medical.Net
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Reviewed by Emily Henderson, B.Sc.Nov 16 2020
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.
Since that time, evidence in favor of the use of sodium/glucose cotransporter 2 (SGLT2) inhibitors has been mounting, with studies showing better blood glucose control, cardiovascular benefits, weight loss and more for patients with diabetes taking SGLT2 inhibitors.
Now, two large clinical trials, conducted by investigators at…
-
General16 hours agoJudge declares mistrial on one of three Harvey Weinstein rape charges
-
Noosa News23 hours agoWhich former PM featured in the King’s Birthday list? Take the Brisbane Times Quiz
-
General19 hours agoChinese captain jailed for three years for cutting an undersea cable off Taiwan
-
General15 hours agoTrump to drive a hard bargain with PM over subs deal